🔗 Share this article

The top legal official in Texas Paxton is suing the manufacturers of acetaminophen, asserting the companies concealed potential risks that the drug created to children's brain development.

This legal action arrives thirty days after President Donald Trump promoted an unsubstantiated connection between using Tylenol - referred to as acetaminophen - while pregnant and autism in children.

The attorney general is suing the pharmaceutical giant, which previously sold the drug, the sole analgesic approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "deceived the public by making money from suffering and marketing drugs without regard for the risks."

The manufacturer says there is insufficient reliable data tying acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening numerous people to increase profits," the attorney general, from the Republican party, declared.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the potential impact that could have on the welfare of American women and children."

On its online platform, Kenvue also said it had "consistently assessed the pertinent research and there is no credible data that shows a established connection between using paracetamol and autism."

Groups acting on behalf of physicians and medical practitioners concur.

The leading OB-GYN organization has said paracetamol - the key substance in Tylenol - is among limited choices for women during pregnancy to manage pain and elevated temperature, which can create serious health risks if ignored.

"In over twenty years of investigation on the use of paracetamol in pregnancy, no reliable research has successfully concluded that the usage of paracetamol in any period of gestation leads to brain development issues in children," the organization said.

This legal action references latest statements from the previous government in asserting the drug is potentially dangerous.

In recent weeks, the former president caused concern from health experts when he instructed women during pregnancy to "struggle intensely" not to use acetaminophen when ill.

Federal regulators then issued a notice that physicians should consider limiting the use of Tylenol, while also mentioning that "a proven link" between the drug and autism in minors has not been established.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had promised in spring to undertake "a massive testing and research effort" that would identify the cause of autism in a matter of months.

But experts warned that discovering a single cause of autism spectrum disorder - believed by scientists to be the consequence of a complex mix of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a type of enduring cognitive variation and disability that affects how persons encounter and interact with the world, and is identified using doctors' observations.

In his court filing, Paxton - a Trump ally who is running for US Senate - alleges Kenvue and J&J "intentionally overlooked and tried to quiet the evidence" around paracetamol and autism.

This legal action attempts to require the companies "eliminate any promotional materials" that claims Tylenol is reliable for women during pregnancy.

This legal action parallels the concerns of a assembly of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in recently.

Judicial authorities dismissed the case, saying investigations from the plaintiffs' authorities was not conclusive.